Influenza Hemagglutinin (HA) Peptide: Atomic Benchmarks for HA Tag Protein Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence YPYDVPDYA) is a precisely defined, nine-amino acid synthetic epitope tag widely employed in protein detection and purification (APExBIO). It competitively binds Anti-HA antibodies, enabling efficient elution of HA-tagged proteins during immunoprecipitation assays (Wei et al., 2021). The peptide exhibits exceptional solubility in water (≥46.2 mg/mL), ethanol (≥100.4 mg/mL), and DMSO (≥55.1 mg/mL) at 20°C, supporting diverse buffer systems. High purity (>98%) is validated by HPLC and mass spectrometry, ensuring reproducibility in molecular workflows. The HA tag peptide supports sensitive protein-protein interaction studies and is integral to advanced exosome pathway research (LabPE).

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is derived from an epitope region of the human influenza hemagglutinin protein, a viral surface glycoprotein critical for host cell entry (Wei et al., 2021). The HA tag sequence (YPYDVPDYA) is not present in most host proteomes, making it an ideal molecular tag for heterologous expression systems (LabPE). Its compact size minimizes steric hindrance and functional disruption of fusion proteins. HA tag technology enables detection, quantification, and purification of recombinant proteins through well-characterized antibody interactions. This approach facilitates studies of protein localization, interaction, and post-translational modifications. The HA peptide's utility extends to exosome research, where tagged proteins can be selectively enriched for vesicular trafficking analysis (PamidronateDisodium).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide functions as an epitope tag by binding specifically and competitively to Anti-HA antibodies. When fused to a protein of interest, it enables targeted detection and affinity purification. During immunoprecipitation or pull-down assays, Anti-HA antibodies immobilized on beads capture HA-tagged proteins. Addition of excess synthetic HA peptide (e.g., APExBIO SKU A6004) competitively displaces the tagged protein via antibody binding site saturation, facilitating gentle elution under non-denaturing conditions (Flag-Peptide). The high affinity and specificity of the Anti-HA/HA tag interaction underpin the robustness of this workflow. The peptide's solubility profile (≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) ensures compatibility with various elution and buffer systems. This mechanism preserves protein-protein and protein-complex integrity, which is critical for downstream functional and structural assays. Competitive binding is a key step in optimizing protein recovery and reducing background signal (FDX1-mRNA).

Evidence & Benchmarks

• High-purity synthetic HA peptide (>98% by HPLC and MS) ensures reproducible immunoprecipitation results (APExBIO).
• Confirmed solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at 20°C (APExBIO).
• Competitive elution of HA-tagged proteins using 1–2 mg/mL HA peptide achieves >90% recovery in standard immunoprecipitation protocols (LabPE).
• The HA tag does not disrupt most protein structures or functions due to its short length (9 amino acids) (Flag-Peptide).
• ESCRT-independent exosome pathway studies have used HA tag fusion constructs to track protein trafficking and secretion in mammalian systems (Wei et al., 2021).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is extensively applied in:

• Protein detection and quantification via Western blot, ELISA, and immunofluorescence (APExBIO).
• Affinity purification of HA-tagged fusion proteins from cell lysates without denaturation (FDX1-mRNA).
• Protein-protein interaction studies, including co-immunoprecipitation and mass spectrometry identification (LabPE).
• Exosome pathway investigations, where HA-tagged proteins are tracked through vesicular compartments (Wei et al., 2021).

For a detailed analysis of the HA tag's mechanistic value in protein interaction studies and translational research, see this review, which this article extends by offering atomic purity and workflow benchmarks. For hands-on protocol optimization, this application note focuses on reproducibility, while the present dossier provides product-specific performance metrics.

Common Pitfalls or Misconceptions

• The HA tag is not universally inert; in rare cases, fusion at critical domains may disrupt protein folding or function.
• HA peptide-based competitive elution is ineffective with non-HA-specific antibodies or if the tag is inaccessible within a protein complex.
• Long-term storage of dilute peptide solutions leads to degradation; peptides should be stored desiccated at -20°C and reconstituted fresh (APExBIO).
• Endogenous HA-like sequences in certain viral or rare host proteins may produce false positives in immunodetection assays (hypothetical, sequence-dependent).
• The peptide sequence (YPYDVPDYA) must be matched to the antibody clone used; cross-reactivity varies among anti-HA antibody sources.

Workflow Integration & Parameters

Integrating the Influenza Hemagglutinin (HA) Peptide into experimental workflows involves several defined steps:

1. Clone the HA tag in-frame at the N- or C-terminus of the target protein's coding sequence (see internal Q&A for optimization scenarios; this article adds quantitative storage and purity parameters).
2. Express the fusion protein in the desired host system (e.g., mammalian, yeast, or bacterial cells).
3. Lyse cells under non-denaturing conditions to preserve protein interactions.
4. Incubate lysates with Anti-HA magnetic beads or resin to capture HA-tagged proteins.
5. Elute bound proteins by adding 1–2 mg/mL synthetic HA peptide in compatible buffer (e.g., PBS, 20°C, pH 7.4).
6. Analyze eluates by SDS-PAGE, mass spectrometry, or functional assays.

For advanced strategies in exosome pathway research leveraging the HA tag, refer to this analysis, which is complemented here by detailed solubility and stability figures.

Conclusion & Outlook

The APExBIO Influenza Hemagglutinin (HA) Peptide (SKU A6004) is a validated, high-purity tag reagent supporting precise protein detection and purification. Its physicochemical properties, competitive binding, and robust performance in immunoprecipitation workflows underpin its status as an industry standard. Ongoing advances in exosome biology, proteomics, and molecular engineering will further expand the scope of HA tag peptide-based methodologies (Wei et al., 2021). For complete specifications and ordering, visit the Influenza Hemagglutinin (HA) Peptide product page.